The Response of Peripheral Blood Mononuclear Cells of Glioma-Bearing Patients to Stimulation with Microbial Antigen and IL-2: Proliferation and IFN-Gamma Production
Peripheral blood mononuclear cells (PBMC) of malignant gliomabearing patients were stimulated in vitro with a glucomannan-protein antigen of Candida albicans (GMP) or Interleukin-2 (IL-2), then assayed for proliferation and production of Interferon gamma. PBMC of healthy, age and sex matched subjects were the controls. PBMC from glioma-bearing patients did not differ, as a whole, from PBMC of healthy donors in IL-2 or GMP-induced proliferation. However, they showed a definitely lesser ability to produce IFN. The results are discussed in the framework of the impairment of immune responses known to affect alioma-bearing patients.
KeywordsPeripheral Blood Mononuclear Cell Candida Albicans Glioma Patient Healthy Subjects9 Brain Stem Glioma
Unable to display preview. Download preview PDF.
- 1.Ommaya AK (1986) Immunotherapy of gliomas: a review. Adv Neurol 15: 337–354Google Scholar
- 2.Terry WD, Rosemberg SA (eds) (1982) Immunotherapy of human cancer. Elsevier, North-Holland, New YorkGoogle Scholar
- 10.Gillis S, Ferm MM, Ou W, Smith KA (1978) T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 120: 2077–2085Google Scholar
- 13.Ausiello C, Spagnoli GC, Antonelli G, Malavasi F, Dianzani F, Casciani CU, Cassone A (1987) Generation and characterization of cytotoxic activity against tumour cell lines in human peripheral blood mononuclear cells stimulated in vitro by a glucomannan-protein preparation of Candida albicans. J Biol Reg Homeost Agents 1: 1Google Scholar
- 14.Rosemberg S (1985) Lymphokine-activated killer cells: a new approach to immunotherapy of cancer. JNCI 75: 595–603Google Scholar